Emerging pharmacological strategies in the fight against cocaine addiction

Expert Opin Emerg Drugs. 2006 Mar;11(1):91-8. doi: 10.1517/14728214.11.1.91.

Abstract

Cocaine addiction continues to be an important public health problem worldwide. At present, there are no proven pharmacotherapies for cocaine addiction. The studies reviewed here revealed a number of emerging targets for cocaine pharmacotherapy. First, disulfiram, a medication with dopaminergic effects, reduced cocaine use in a number of clinical trials. Second, GABA medications, tiagabine and topiramate, were found promising in clinical trials. Third, a beta-adrenergic blocker, propranolol, may be effective especially among cocaine-addicted individuals with high withdrawal severity. Fourth, treatment with a stimulant medication, modafinil, has reduced cocaine use. Last, a cocaine vaccine that slows entry of cocaine into the brain holds promise. These promising findings need to be further tested in controlled clinical trials.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Animals
  • Benzhydryl Compounds / therapeutic use
  • Brain / drug effects*
  • Brain / enzymology
  • Central Nervous System Stimulants / therapeutic use
  • Cocaine / immunology
  • Cocaine-Related Disorders / drug therapy*
  • Disulfiram / pharmacology
  • Disulfiram / therapeutic use
  • Dopamine / metabolism
  • Dopamine Agents / pharmacology
  • Dopamine Agents / therapeutic use
  • Dopamine beta-Hydroxylase / antagonists & inhibitors
  • Dopamine beta-Hydroxylase / metabolism
  • Drug Evaluation, Preclinical
  • Enzyme Inhibitors / therapeutic use
  • GABA Agonists / therapeutic use
  • GABA Plasma Membrane Transport Proteins / metabolism
  • GABA Uptake Inhibitors
  • Humans
  • Modafinil
  • Nipecotic Acids / therapeutic use
  • Propranolol / therapeutic use
  • Randomized Controlled Trials as Topic
  • Tiagabine
  • Vaccines / therapeutic use
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Adrenergic beta-Antagonists
  • Benzhydryl Compounds
  • Central Nervous System Stimulants
  • Dopamine Agents
  • Enzyme Inhibitors
  • GABA Agonists
  • GABA Plasma Membrane Transport Proteins
  • GABA Uptake Inhibitors
  • Nipecotic Acids
  • SLC6A1 protein, human
  • Vaccines
  • gamma-Aminobutyric Acid
  • Propranolol
  • Dopamine beta-Hydroxylase
  • Cocaine
  • Modafinil
  • Disulfiram
  • Dopamine
  • Tiagabine